Lisha Sun

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer.⚑
  2022 L1 45/100 ⚑

1 assessed by us (0 reproduced) · 74 not yet assessed — every PubMed paper on record, linked below.

• Paget's disease of the breast misdiagnosed as eczema ↗

  Asian Journal of Surgery · 2026
  not yet assessed
• Choosing a valid analysis for high-frequency wearable data in N-of-1 trials: a practical guide ↗

  SSRN Electronic Journal · 2026
  not yet assessed
• Ultrathin Cellulose Ionogel Devices Through Solvent‐Induced Peeling ↗

  Advanced Functional Materials · 2025
  not yet assessed
• CD8+ TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patients ↗

  Signal Transduction and Targeted Therapy · 2025 · PMID 41062493
  not yet assessed
• Correction: Targeting SOST using a small‑molecule compound retards breast cancer bone metastasis ↗

  Molecular Cancer · 2025 · PMID 40241133
  not yet assessed
• Erratum to: FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway ↗

  Science China Life Sciences · 2025 · PMID 40549239
  not yet assessed
• Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer ↗

  Molecular Cancer · 2025 · PMID 40229879
  not yet assessed
• Correction: Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer ↗

  eLife · 2025 · PMID 40338227
  not yet assessed
• Erratum to “A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+ CD24- enriched breast cancer stem-like cells” [Drug Resist. Updates 66 (2023) 100903] ↗

  Drug Resistance Updates · 2025 · PMID 40912935
  not yet assessed
• Correction: Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis ↗

  eLife · 2025 · PMID 40928840
  not yet assessed
• <i>CEMIP</i> as a potential biomarker and therapeutic target for breast cancer patients: Erratum ↗

  International Journal of Medical Sciences · 2025 · PMID 41049451
  not yet assessed
• Clinical Management of Herpes Zoster Complicated by MRSA Infection ↗

  Clinical Cosmetic and Investigational Dermatology · 2025 · PMID 41332507
  not yet assessed
• Effects of &amp;lt;italic&amp;gt;Sancai Lianmei Granule&amp;lt;/italic&amp;gt;（三才连梅颗粒） on autophagy in testicular spermatogenic cells and the PI3K/AKT/mTOR signaling pathway in obese mice ↗

  Lishizhen Medicine and Materia Medica Research · 2025
  not yet assessed
• Lower Visceral Fat is Related to Diabetic Peripheral Neuropathy ↗

  Diabetes Metabolic Syndrome and Obesity · 2024 · PMID 39139742
  not yet assessed
• PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma ↗

  The American Journal of Surgical Pathology · 2024 · PMID 38682454
  not yet assessed
• A 6-year retrospective study of olanzapine plasma concentration inpatients with schizophrenia CYP1A2 polymorphisms in real-life settings ↗

  Heliyon · 2024 · PMID 39498058
  not yet assessed
• Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer ↗

  Molecular Cancer · 2024 · PMID 38183152
  not yet assessed
• Clinical application of the femoral neck system for elderly patients with osteoporotic femoral neck fracture: A preliminary report ↗

  Asian Journal of Surgery · 2024 · PMID 39069415
  not yet assessed
• Upfront Stereotactic Body Radiotherapy to the Residual Primary Lung Lesions after First-Line Systemic Therapy in Polymetastatic Non-Small Cell Lung Cancer ↗

  International Journal of Radiation Oncology*Biology*Physics · 2024
  not yet assessed
• CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer ↗

  Molecular Cancer · 2023 · PMID 36627608
  not yet assessed
• KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer ↗

  Nature Communications · 2023 · PMID 37147285
  not yet assessed
• Antioxidant and anti-inflammatory properties of ginsenoside Rg1 for hyperglycemia in type 2 diabetes mellitus: systematic reviews and meta-analyses of animal studies ↗

  Frontiers in Pharmacology · 2023 · PMID 37745069
  not yet assessed
• FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway ↗

  Science China Life Sciences · 2023 · PMID 37460715
  not yet assessed
• KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes ↗

  Asian Journal of Pharmaceutical Sciences · 2023 · PMID 37274925
  not yet assessed
• Early Stereotactic Body Radiotherapy to the Primary Lung Lesion for Patients with Advanced NSCLC Treated with First-Line Systemic Therapy ↗

  International Journal of Radiation Oncology*Biology*Physics · 2023
  not yet assessed
• KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer ↗

  Figshare · 2023
  not yet assessed
• Targeting SOST using a small-molecule compound retards breast cancer bone metastasis ↗

  Molecular Cancer · 2022 · PMID 36581888
  not yet assessed
• A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cells ↗

  Drug Resistance Updates · 2022 · PMID 36463808
  not yet assessed
• NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer⚑

  Frontiers in Pharmacology · 2022 · PMID 35431924
  L1 45/100 ⚑
• Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study ↗

  Frontiers in Oncology · 2022 · PMID 36091103
  not yet assessed
• Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer ↗

  eLife · 2022 · PMID 36602226
  not yet assessed
• <i>CEMIP</i> as a potential biomarker and therapeutic target for breast cancer patients ↗

  International Journal of Medical Sciences · 2022 · PMID 35370456
  not yet assessed
• Author response: Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer ↗

  2022
  not yet assessed
• Dalpiciclib Partially Abrogates ER Signaling Activation Induced by Pyrotinib In HER2 ⁺ HR ⁺ Breast Cancer ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Long-Term Outcomes by Neoadjuvant Efficacy Indexes in Patients with HR and HR /HER2 Breast Cancer after Neoadjuvant Systemic Therapy: A Systematic Review and Meta-Analysis ↗

  SSRN Electronic Journal · 2022
  not yet assessed
• Author response: Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer ↗

  2022
  not yet assessed
• Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer ↗

  eLife · 2022 · PMID 35285795
  not yet assessed
• Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis ↗

  eLife · 2021 · PMID 34318746
  not yet assessed
• Tianchang Capsule prevents ovariectomy induced osteoporosis in rats ↗

  Food Science and Technology · 2021
  not yet assessed
• Dalpiciclib and Pyrotinib Exert Synergistic Antitumor Effects in Triple Positive Breast Cancer ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• Author response: Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis ↗

  2021
  not yet assessed
• BAG2 Promotes Proliferation and Metastasis of Gastric Cancer via ERK1/2 Signaling and Partially Regulated by miR186 ↗

  Frontiers in Oncology · 2020 · PMID 32082999
  not yet assessed
• HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer ↗

  Frontiers in Oncology · 2020 · PMID 33425760
  not yet assessed
• <i>HCK</i> can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients ↗

  International Journal of Medical Sciences · 2020 · PMID 33162805
  not yet assessed
• LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer ↗

  Journal of Cellular and Molecular Medicine · 2020 · PMID 32618099
  not yet assessed
• FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis ↗

  International Journal of Medical Sciences · 2020 · PMID 33162809
  not yet assessed
• Clinical Implications of <i>HSC70</i> Expression in Clear Cell Renal Cell Carcinoma ↗

  International Journal of Medical Sciences · 2020 · PMID 33390792
  not yet assessed
• Effect of sancai powder on glacemic variability of type 1 diabetes in China ↗

  Medicine · 2020 · PMID 32846751
  not yet assessed
• The effect of Sancai powder on glycemic variability of type 2 diabetes in the elderly ↗

  Medicine · 2020 · PMID 32756078
  not yet assessed
• Association of CD44 ⁻ /CD24 ⁻ Breast Cancer Cells with Late Stage Tumor Recurrence ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway ↗

  Frontiers in Oncology · 2019 · PMID 31338333
  not yet assessed
• Establishment and Verification of a Bagged-Trees-Based Model for Prediction of Sentinel Lymph Node Metastasis for Early Breast Cancer Patients ↗

  Frontiers in Oncology · 2019 · PMID 31041192
  not yet assessed
• RILPL2 regulates breast cancer proliferation, metastasis, and chemoresistance via the TUBB3/PTEN pathway. ↗

  PubMed · 2019 · PMID 31497344
  not yet assessed
• Surgical Outcomes of Implant-based Breast Reconstruction Using TiLoop Bra Mesh Combined With Pectoralis Major Disconnection ↗

  Annals of Plastic Surgery · 2019 · PMID 31524731
  not yet assessed
• Knockdown of endothelin receptor B inhibits the progression of triple‐negative breast cancer ↗

  Annals of the New York Academy of Sciences · 2019 · PMID 30900271
  not yet assessed
• Post-Discharge Short Message Service Improves Short-Term Clinical Outcome and Self-Care Behaviour in Chronic Heart Failure ↗

  ESC Heart Failure · 2018 · PMID 30478888
  not yet assessed
• FSIP1 regulates autophagy in breast cancer ↗

  Proceedings of the National Academy of Sciences · 2018 · PMID 30509973
  not yet assessed
• Association of IL-8 gene promoter -251 A/T and IL-18 gene promoter -137 G/C polymorphisms with head and neck cancer risk: a comprehensive meta-analysis ↗

  Cancer Management and Research · 2018 · PMID 30127645
  not yet assessed
• SND1 expression in breast cancer tumors is associated with poor prognosis ↗

  Annals of the New York Academy of Sciences · 2018 · PMID 30216461
  not yet assessed
• TUFT1 is expressed in breast cancer and involved in cancer cell proliferation and survival ↗

  Oncotarget · 2017 · PMID 29088838
  not yet assessed
• Prognostic significance of GSTP1 in patients with triple negative breast cancer ↗

  Oncotarget · 2017 · PMID 28978147
  not yet assessed
• Predicting level 2 axillary lymph node metastasis in a Chinese breast cancer population post-neoadjuvant chemotherapy: development and assessment of a new predictive nomogram ↗

  Oncotarget · 2017 · PMID 29108294
  not yet assessed
• Application effects of nurse-led chronic disease management clinic in patients with cardiovascular disease ↗

  Zhonghua xiandai huli zazhi · 2017
  not yet assessed
• Application research of multidisciplinary team management mode in interventions for patients with coronary heart disease ↗

  Zhonghua xiandai huli zazhi · 2016
  not yet assessed
• Abstract P4-03-12: diagnostic value and clinical significance of integrin αvβ3 in breast mass ↗

  Cancer Research · 2012
  not yet assessed
• A study of effectiveness and safety of insulin glargine in the treatment of patients with type 2 diabetes mellitus

  2012
  not yet assessed
• Be alert to tuberculosis-mediated glomerulonephritis: a retrospective study ↗

  European Journal of Clinical Microbiology & Infectious Diseases · 2011 · PMID 21822562
  not yet assessed
• PII-46Sitagliptin (MK-0431), a selective dipeptidyl-peptidase-IV (DPP-IV) inhibitor, does not affect the pharmacokinetics of simvastatin in humans ↗

  Clinical Pharmacology & Therapeutics · 2006
  not yet assessed
• Effects of timosaponins on learning and memory abilities of rats with dementia induced by lateral cerebral ventricular injection of amyloid beta- peptide. ↗

  PubMed · 2005 · PMID 15698986
  not yet assessed
• [Lipoprotein glomerulopathy: a case report]. ↗

  PubMed · 2005 · PMID 16251059
  not yet assessed
• Sitagliptin (MK-0431), a Selective Dipeptidyl-Peptidase-IV (DPP-IV) Inhibitor, does not affect the Pharmacokinetics of Simvastatin in Humans. 2005; 79: P48

  VUBIR (Vrije Universiteit Brussel) · 2005
  not yet assessed
• [Effects of Capsule Yizhi on the delayed neuronal death in hippocampal CA1 region and memory function after global cerebral ischemia in rats]. ↗

  PubMed · 2004 · PMID 15551967
  not yet assessed
• [Effects of nitric oxide synthase inhibitor on dentate gyrus neurogenesis after diffuse brain injury in adult rats]. ↗

  PubMed · 2003 · PMID 14559698
  not yet assessed
• [A case-control study on relationship between body mass index and lung cancer in non-smoking women]. ↗

  PubMed · 1999 · PMID 11864446
  not yet assessed
• Effect of procainamide on pulmonary thromboembolism and platelet malondialdehyde in mice. ↗

  PubMed · 1996 · PMID 9863141
  not yet assessed